Carlos-Blas-López

Carlos Blas López

Médico adjunto
Specialty:
Hematology and hemotherapy
Serving specialties:
  • Hematology
Hospitals where he/she works:
  • Hospital Universitario Fundación Jiménez Díaz
General Information
Experience
  • 2010–Present: Consultant in Hematology. Molecular Biology and Eritropathology Laboratory . Fundación Jiménez Díaz
  • 1999–2010: Consultant in Hematology. Molecular Biology Laboratory GEMOLAB /Madrid
  • 1995–1998: Resident in Hematology and Hemotherapy / Hospital Universitario de la Princesa
Degree
  • Bachelor of Medicine and Surgery, Autonomous University of Madrid (1987-1993)
  • Specialist in Hematology and Hemotherapy (1995–1998)
Techniques

Nucleic acid extraction, PCR, qPCR, digital PCR, fragment analysis, Sanger Sequencing and NGS (molecular biology) and HPLC and molecular studies in Eritopathology

Research and teaching

Research:

  • Codirector of final degree project : "Correlation between hematology laboratory parameters and genetic mutations in beta thalassemia. A study of 164 cases". D. Boianelli, Facultad de Medicina. Universidad Autónoma de Madrid, 2017

Taching:

  • Teaching collaborator Universidad Autonoma de Madrid (UAM)
  • Teaching collaborator Universidad Rey Juan Carlos (URJC)
  • Teaching collaborator Universidad Alfonso X (UAX)
  • Tutor of residents, Hematology Department, Fundación Jiménez Díaz (2012-2016)
Publications

1. Persistent polyclonal B-cell lymphocytosis in a middle-aged, smoking woman with typical morphologic and genetic hallmarks. PMID: 11532639
2. Deletion of sequences flanking the t (9; 22) breakpoint: a secondary genetic event associated with loss of cytogenetic response to interferon in a Philadelphia-positive chronic myeloid leukaemia patient. DOI: 10.1046/j.1365-2141.2002.03432.x
3. High molecular response rate and clinical correlation in patients with follicular lymphoma treated with cyclophosphamide-vincristine-prednisone plus interferon alpha 2b.
PMID: 12855623
4. The prevalence of hepatitis C virus infection in patients with non-Hodgkin's lymphoma. PMID: 15075985
5. Evaluation of CD7 and Terminal deoxynucleotidyl transferase (TdT) expression in CD34+ myeloblasts from patients with myelodysplastic syndrome. PMID: 16417922
6. Clonal evolution in patients with chronic lymphocytic leukemia. PMID: 20443678
7. Cut-off Values of Hematologic Parameters to Predict the Number of Alpha Genes Deleted in Subjects with Deletional Alpha Thalassemia doi: 10.3390/ijms18122707.
8. Comparison of Droplet Digital PCR versus qPCR Measurements on the International Scale for the Molecular Monitoring of Chronic Myeloid Leukemia Patients. Molecular Diagnosis & Therapy. 24, pp.593–600. doi: 10.1007/s40291-020-00485-4
9. Lymphoplasmacytic lymphoma associated with diffuse large B-cell lymphoma: Progression or divergent evolution? PMID: 3318088
10. Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens. Scientific Reports. 11-20745. doi: 10.1038/s41598-021-00050-x
11. ZBTB16-RARα-Positive Atypical Promyelocytic Leukemia: A Case Report
Medicina 2022, 58, 520. https://doi.org/10.3390/medicina58040520
12. Spontaneous Remission of Acute Myeloid Leukemia: A Case Report Medicina. 2022; 58(7):921. doi:10.3390/medicina58070921
13. Spontaneous Remission of Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report. Medicina. doi: 10.3390/medicina60050807.
14. No evidence that CD33 rs12459419 polymorphism predicts gemtuzumab ozogamicin response in consolidation treatment of acute myeloid leukemia patients: experience of the PETHEMA group. Disease Markers. 2022. doi: 10.1155/2022/3132941.
15. Flow Cytometry Analysis of Mesenchymal Stem Cells: A Predictive Biomarker for Leukemia Transformation in Myelodysplastic Syndrome. eJHaem 2025 doi.org/10.1002/jha2.70059
16. Tratamiento de los linfomas indolentes. En "Terapia en Oncohematología", Hartcourt Brace 1998.
17. - Hemocromatosis. Monografía XX ("Enfermedades metabólicas") de la Real Academia Nacional de Farmacia, 2006.
-Hemocromatosis. Manual práctico de genética hematológica (2016). ISBN 978-84-608-1494-8


Communications and Presentations
  • Oral comunication: " High molecular response rate in patients with low grade non hodgkin´s lymphoma treated with cvp and interferon alfa 2b"). 2000 Anual Meeting of the American Society of Hematology, San Francisco.
  • Talk:" Treatment of iron deficiency anemia. Iron preparations. Selection criteria" III Course on Rational Use of Medication, organized by the General Directorate of Primary Care of Area 2 (January 1997)).
  • Talk: Diploma Course in Occupational Nursing at the National School of Occupational Medicine (June 1997)
  • Talk: Applications of Molecular Biology to the Diagnosis of Non-Neoplastic Hematological Diseases. Doctoral Course F. of Medicine UAM (2003).
  • Talk: Hemochromatosis: Epidemiology, Clinical Features, and Treatment. Refresher Course in Hematology . Clínica Moncloa. 2005. Spain
  • Talk: Applications of Molecular Biology to Clinical Practice in Hematology. Refresher Course in Hematology . Clínica Moncloa. 2005. Spain
  • Talk: 1st CML Update Conference . 2011. Spain
  • Talk: 2nd CML Update Conference . 2012. Spain
  • Talk : Diagnostic and therapeutic update in AML: Detection of measurable residual disease in AML . 2023. Spain